Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It’s definitely more then usual volume but still very low for this company if you consider potential they have.
That's pretty heavy volume. Wonder if someone knows something. I doubt this move has to do with the trademark news.
I really wonder why some of these market makers are dropping bids constantly
Cooool this price action, some of the "Hosenscheisser" get out ... cu at 30 cents
Hi CDEL show us how many shares u have, i know a buyer or do u want to lower the price every day...
That was mistake and I contacted Andre. It’s corrected
Yes, I've been invested in ADMT for several years and have a fairly large holding. But this seller must be sitting on several million shares because he appears to have been unloading for months. Every time the price nudges up, it seems to get smashed right back down.
Citadel Sec. and nobody knows how many, but when they are finished i expect it to go back to 15-20 cents. Because it is a very interesting company with a lot of innovation and no dept.! About 50% of the outstanding shares are owened by the DiMino family!
Does anyone know why this has sunk so low?
They had a great quarterly report, considering they're still operating under COVID. Their revenue has come back up to pre-COVID levels, but their stock price has gone down since that report.
Ah...you are correct.
I forgot the August update I had saved was incorrect. It was already mentioned here that the TA had submitted an incorrect update with the Aug numbers i saw.
So...in summary....no dilution.
Craig 305, i think thats wrong! It was the same as it is now back in 2016!
Common stock, $0.0005 par value; 150,000,000 authorized, 67,008,502 shares issued and outstanding at March 31, 2016.
They have enough cash.....
www.otcmarkets.com in the security details section.
I have a screen image from August update and comparing to the December update.
Craig305
Where did u see this with more shares in the float? I can't find it, do you have a source?
TX
Seems the company is putting some more shares into the float. With no buying pressure, the dilution is pushing share price down.
Has added 10 million shares to the outstanding share count since August.
Some of the 10 are restricted.
interest in this stock is so low.
Hey CDEL, how many shares do u have left? You are always try to lower the ask/offer side, whenever higher prices are paid, then u show up with a low ball offer! Show the size, somebody out there could be interested in a Block, then u can stop this nonsense.
ADM Tronics Reports Second Quarter of Fiscal Year 2021 Results
November 16, 2020 - Northvale, NJ – ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its second fiscal quarter ended September 30, 2020 of Fiscal Year 2021.
ADM Tronics’ second fiscal quarter ended September 30, 2020 showed improvement in operational results as compared to the first fiscal quarter ended June 30, 2020 despite continued effects of the COVID-19 pandemic. Throughout the pandemic, ADMT implemented aggressive steps to minimize disruption of operations including securing Essential Manufacturer exemption from the statewide shutdown and encompassing CDC safety guidelines in ADMT’s operations. This allowed continued research, development and manufacturing operations throughout the period.
Revenues for the second fiscal quarter ended September 30, 2020 were $927,085 as compared to the first fiscal quarter ended June 30, 2020 of $569,093 an increase of approximately 63%.
“We are pleased to have achieved increased revenues for the second quarter as compared to our first fiscal quarter of fiscal year 202, although the effects of the pandemic continue to present challenges as many of our customers report reduced business activities,” stated Andre’ DiMino, President of ADM Tronics. “We continued the trend in growth of manufacturing revenues reported in our first fiscal quarter with $396,910 for the three months and $684,972 for the six months ended September 30, 2020 an increase of 41% and 57% respectively as compared to the same periods in the last fiscal year for our manufacturing segment. Chemical and engineering segment revenues were lower as compared to the same periods in fiscal year 2019 due to the effects of the pandemic on our customers. We continued to invest in our future by advancing research and development into our own proprietary medical technology developments, which we firmly believe will prove meaningful to our future growth and profits.”
Revenues for the three months ended September 30, 2020 were $927,085 as compared to $956,791 for the three months ended September 30, 2019, a decrease of 3% primarily due to reduced engineering and chemical segment revenues from the effects of the pandemic on customers, offset by increased manufacturing revenues. Income from operations for the second quarter was $5,366 as compared to loss of $43,748 for the same period last year.
Revenues for the six months ended September 30, 2020 were $1,496,178 as compared to $1,787,612 for the six months ended September 30, 2019, a decrease of 16%. Loss from operations for the second quarter was $178,504 as compared to income of $25,537 for the same period last year. The decrease in revenues was primarily from reduced engineering and chemical revenues during the first quarter of 2020 ended June 30, 2020 from the effects of the pandemic on customers, offset by an increase in manufacturing revenues for the period.
I wish it was me.
Put u orders in at 9 cents and get some cheap shares from CDEL,
mine is in
Tuesday, October 06 2020 12:48 PM, EST Novel Therapeutic Technology Developed and Manufactured by ADM Tronics for Origin, Inc., Submitted to FDA for Investigational Exemption to Conduct Studies on COVID Patients GlobeNewswire "Press Releases"
Northvale, NJ , Oct. 06, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire--ADM Tronics Unlimited, Inc. (OTCQB: ADMT) has been advised that Origin, Inc. filed an Investigational Device Exemption (IDE) application with the FDA to conduct clinical studies to treat patients diagnosed with COVID-19 with its plasma-generated nitric oxide (NO) technology. ADMT has been developing and has manufactured for Origin, Inc. the IonoJet, which allows for targeted delivery of NO generated by a thermal plasma, produced from room air at the point of therapy.
Michael Preston , Chairman and President of Origin, Inc. , stated, "Like other nitric oxide companies, we have recognized the potential ability of NO to stop the replication of corona viruses. We believe there may be limitations with other approaches, and we have worked to address these in a novel system that is designed to allow NO to be administered effectively. ADMT has been key to our development and will play an important part in our future.
In an October 2, 2020 letter to Origin shareholders, Mr. Preston wrote, We have today filed an Investigational Device Exemption (IDE) application with the U.S. Food and Drug Administration (FDA) under the Compassionate Use provisions of the Expanded Access pathway for the use of our plasma-generated nitric oxide (NO) in a physician-sponsored trial to treat patients diagnosed with COVID-19.
We are so pleased to see Origins progress, stated Andre DiMino , President of ADMT. And, we are doubly-pleased and excited to see that a technology we developed and manufactured at ADMT for Origin has the potential to help in the battle against this pandemic.
Origin, Inc. is a Phase IIb clinical-stage biotechnology company that applies its proprietary technology to generate and deliver nitric oxide (NO) from a defined high-energy plasma stream. Visit originww.com.
About ADMT ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Proprietary Medical Devices; Medical Device Design, Engineering, Regulatory and Manufacturing Services; and, Eco-Friendly Formulations from its headquarters, laboratories, and FDA-Registered medical device manufacturing operations. ADMTs multi-disciplinary team of engineers, researchers, and technologists utilize advanced technology infrastructure for R&D and commercialization of diversified technologies. Visit - admtronics.com. Except for historical information contained herein, the matters set forth in this news release are forward-looking statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMTs SEC filings, news releases, and other communications. The Company assumes no obligation to update the information contained in this news release.
Andre DiMino 201-767-6040 andre@admtronics.com
Source: ADM Tronics Unlimited, Inc.
https://www.otcmarkets.com/stock/admt/news/story?e&id=1708371
I think this "always/forever seller" finished with a block!
Would be good news.....
We'll see and hopefully Andre has some other good NEWS
I’m not really sure.
What's with this little crash?
There must be something going on that is not retail investor related.
I see it happening for months now. I’m guessing impatient investors and market makers.
What's up with all the downward selling pressure?
There is no dilution of common shares that I'm aware of.
Impatient investors moving $ elsewhere?
Great. Glad I did not have to upload the photos. Is not the easiest to do on I-Hub.
Have to resize the image and go through a step process I would have had to re-learn again...hehe.
Email from Andre.
..... OK, I found out who caused the problem!!! The transfer agent submitted the numbers incorrectly. They are working on correcting it right now - but it will take a day or so.....
I have screen image from OTC Markets website from 1 year ago and from this month. I can try uploading later when I'm at a computer. Can't upload images from I-HUB phone app.
I asked Andre and everything stayed a same. Where did you see change.
Quarterly ER was released last week.
Covid affected the financials here also.
Decreased revenue and gross profit margin decreased significantly.
Looks like they rely on the chemical sales for a good profit margin.
Interesting. A/S and O/S reduced from last year and no mention of it?
July 2019:
150 million authorized shares
67.5 M outstanding
August 2020:
140 M A/S
57.6 M O/S
I agree. Let them shake shares if they can. I’m still adding on bid and sometimes hitting ask. Their game will not be successful.
Groundhog Day! Paid up to 0.153 for several thousand shares, ten minutes late again someone steps in with a lowball offer/ask at 0.14 cents! Something is going on here, they try to keep the shareprice low...., but this will not be successful, do the DD and then you will see that this stock could be 20-50 cents at the end of the year! Or call Andre, he will tell u the fascinating story!
Hi GTSM
can you offer me a block instead of keeping the stock price low with u lowball ask prices! Or is this ur intention?
And he’s back again with 5000 on ask at 14
And always 5 or 6k on ask. Same this morning
They are trying to bring price down with 5000 shares on ask. Ridiculous.
Back at .14 weird game
Hey ETRF useless game!
15.5 cents and now 14.5 cents offered.
U will lose this game
There’s couple of them playing with it
As i said! ETRF is back!
Last paid 15.5 cents and then 14 cents offered by ETRF...
Nice game to keep the price lower, but that won't work
Followers
|
14
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
662
|
Created
|
04/21/08
|
Type
|
Free
|
Moderators |
ADM Tronics Unlimited, Inc. engages in the development, manufacture, and sale of environmentally safe chemical products for industrial use; non-toxic composite fabricating resin; non-invasive, electronic therapy technology, electronic development and production, and topical, dermatological products.
Our environmentally safe line of water-based industrial chemical solutions is comprised of primers, adhesives, coatings and additives which are used in food and medical packaging, graphic arts, wall covering and converting industries.
The resins product line consists of a non-toxic composite fabricating resin. This water-based material has numerous uses in such diverse fields as scenic design, architecture, sculpture, and prototype and product development.
The company's electronic therapy technology includes products used in the treatment of joint pain, postoperative edema, and tinnitus. As a contract manufacturer, ADM Tronics, Inc. produces electronic components, assemblies and complete systems on a proprietary and OEM contracted or project basis for customers from diverse industries.
ADM Tronics line of water-based skin adhesives are considered “the industry standard” for use in the special effects makeup industry as well as for medical prosthetic applications. Also included in its skin care line is topical, dermatological products.
It sells its products worldwide. The company was founded by Dr. Alfonso Di Mino. ADM Tronics Unlimited, Inc. was incorporated in 1969 and is headquartered in Northvale, New Jersey, USA. Andre’ DiMino serves as President.
Our Divisions | |
Aqua Based Technologies: Environmentally safe, water-based primers, adhesives, coatings and additives used in the food and medical packaging, graphic arts, wall covering and converting industries. | |
Pros-Aide: Water-based adhesive for the skin. For use in medical prosthetics applications, special effects makeup and other areas of professional makeup. | |
Antistatic Industries: Specialty conductive paints, coatings and products serving the computer, pharmaceutical and chemical fields for the prevention of static electricity damage to personnel, operating plants and to expensive computers & electronic equipment and parts. | |
Our Subsidiaries | |
Sonotron Medical Systems Inc.: Non-invasive electronic therapy technology. | |
Pegasus Laboratories: A line of innovative topical, dermatological products. |
<SHARE STRUCTURE>
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |